Pharmacological studies on 8-[(1,4-benzodioxan-2-yl) methyl]-3-oxo-1-thia-4,8-diazaspiro-[4,5]-decane maleate.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D001011:Aorta / Q000187:drug effects; D001464:Barium / Q000037:antagonists & inhibitors; D001794:Blood Pressure / Q000187:drug effects; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects; D004147:Dioxins / Q000494:pharmacology*; D004285:Dogs; D004837:Epinephrine / Q000037:antagonists & inhibitors; D004983:Ethanolamines / Q000494:pharmacology; D005263:Femoral Artery / Q000187:drug effects; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D008298:Maleates / Q000494:pharmacology; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010208:Papaverine / Q000494:pharmacology; D010477:Perfusion; D010643:Phenoxybenzamine / Q000494:pharmacology; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D012077:Renal Artery / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D013141:Spiro Compounds / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology; D014043:Tolazoline / Q000494:pharmacology; D014649:Vas Deferens / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*
D004147:Dioxins; D004983:Ethanolamines; D008298:Maleates; D013141:Spiro Compounds; D013565:Sympatholytics; D013844:Thiazoles; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D001464:Barium; D014043:Tolazoline; D010208:Papaverine; D000109:Acetylcholine; D009638:Norepinephrine; D004837:Epinephrine